Literature DB >> 3127855

Actions of nicotine on the acquisition of an autoshaped lever-touch response in rats.

W R Mundy1, E T Iwamoto.   

Abstract

Experimentally naive male, Sprague-Dawley rats maintained at 85% of their original body weight were trained to touch a retractable lever that was presented on a random interval 48-s schedule. The lever retracted when touched or after 15 s had elapsed, and one 45 mg food pellet was delivered simultaneously with lever retraction or after an 8-s delay. Rats received ten daily sessions each consisting of ten lever presentations. Nicotine (0.25-0.8 mg/kg SC) administration, either 15 min prior to (pre-session) or immediately after (post-session) the daily autoshaping sessions, caused a significant dose-related impairment of acquisition with the post-session injections having the greater effect. Low doses of nicotine (0.025-0.1 mg/kg SC) had little effect on acquisition when injected pre-session or post-session. Injections of 0.45 mg/kg nicotine either immediately (t = 0) or at +5 min after the daily sessions impaired acquisition of the lever-touch response. Nicotine injected at +15, +30, +60, or +120 min had no effect on acquisition. A single intraventricular injection of the ganglionic blocker chlorisondamine (5 micrograms) 2 weeks prior to autoshaping blocked the impairment produced by 0.45 mg/kg nicotine. Post-session injections of nicotine did not alter the lever-touch behavior of well-trained animals, but suppressed responding in animals that were partially trained. Thus, nicotine-induced impairment of the autoshaped lever-touch response is dose dependent, centrally mediated, occurs within 5 min of a SC injection, and may interfere with post-training consolidation processes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127855     DOI: 10.1007/bf00176858

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Electroconvulsive shock, retrograde amnesia, and competing responses.

Authors:  H E ADAMS; D J LEWIS
Journal:  J Comp Physiol Psychol       Date:  1962-06

2.  Nicotine and caffeine: disruption of the long-term store of memory and proactive facilitation of learning in mice.

Authors:  J S Stripling; H P Alpern
Journal:  Psychopharmacologia       Date:  1974

3.  Consolidation and maze learning: a study of some strain-drug interactions.

Authors:  M Garg; H C Holland
Journal:  Psychopharmacologia       Date:  1969

4.  Facilitation of simultaneous visual discrimination by nicotine in four "inbred" strains of mice.

Authors:  F Bovet-Nitti
Journal:  Psychopharmacologia       Date:  1969

5.  Effects of nicotine on discrimination learning, consolidation and learned behaviour in two inbred strains of mice.

Authors:  C Castellano
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

6.  Delaying reinforcement in an autoshaping task generates adjunctive and superstitious behaviors.

Authors:  R B Messing; M S Kleven; S B Sparber
Journal:  Behav Processes       Date:  1986-12       Impact factor: 1.777

7.  Effects of mecamylamine on avoidance conditioning and maze learning of mice.

Authors:  A Oliverio
Journal:  J Pharmacol Exp Ther       Date:  1966-11       Impact factor: 4.030

8.  Time-dependent processes in memory storage.

Authors:  J L McGaugh
Journal:  Science       Date:  1966-09-16       Impact factor: 47.728

9.  Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: a review and some new results.

Authors:  G Bammer
Journal:  Neurosci Biobehav Rev       Date:  1982       Impact factor: 8.989

10.  Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions.

Authors:  B R Martin; H L Tripathi; M D Aceto; E L May
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

View more
  11 in total

1.  Timing of nicotine effects on learning in zebrafish.

Authors:  Edward D Levin; Joy Limpuangthip; Tara Rachakonda; Miram Peterson
Journal:  Psychopharmacology (Berl)       Date:  2005-09-21       Impact factor: 4.530

2.  Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats.

Authors:  T Marenco; S Bernstein; P Cumming; P B Clarke
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats.

Authors:  J Turchi; L A Holley; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

4.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]-chlorisondamine.

Authors:  H el-Bizri; M G Rigdon; P B Clarke
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.

Authors:  H el-Bizri; P B Clarke
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

7.  Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.

Authors:  Nurith Amitai; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2008-07-11       Impact factor: 4.530

8.  The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.

Authors:  P B Clarke; I Chaudieu; H el-Bizri; P Boksa; M Quik; B A Esplin; R Capek
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

9.  Nicotine effects on learning in zebrafish: the role of dopaminergic systems.

Authors:  Donnie Eddins; Ann Petro; Paul Williams; Daniel T Cerutti; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2008-08-21       Impact factor: 4.530

10.  Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo.

Authors:  H el-Bizri; P B Clarke
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.